No Data
No Data
Insider Sale: SVP & CFO of $BVS Sells 5,479 Shares
Healthcare Up as Traders Rotate to Less Inflation-Sensitive Sectors -- Health Care Roundup
Bioventus Is Maintained at Buy by Canaccord Genuity
Bioventus Price Target Maintained With a $15.00/Share by Canaccord Genuity
Bioventus Analyst Ratings
CCORF Maintains Bioventus(BVS.US) With Buy Rating, Maintains Target Price $15